ArticleSensors (Basel, Switzerland)2025
Deep Learning-Based Assessment of Brainstem Volume Changes in Spinocerebellar Ataxia Type 2 (SCA2): A Study on Patients and Preclinical Subjects.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Improving the Identification of the Preclinical Stages of Spinocerebellar Ataxia Type 2.Tomography (Ann Arbor, Mich.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disorder marked by progressive brainstem and cerebellar atrophy, leading to gait ataxia. Quantifying this atrophy in magnetic resonance imaging (MRI) is critical for tracking disease progression in both symptomatic patients and preclinical subjects. However, manual segmentation of brainstem subregions (mesencephalon, pons, and medulla) is time-consuming and prone to human error. This work presents an automated deep learning framework to assess brainstem atrophy in SCA2. Using T1-weighted MRI scans from patients, preclinical carriers, and healthy controls, a U-shaped convolutional neural network (CNN) was trained to segment brainstem subregions and quantify volume loss. The model achieved strong agreement with manual segmentations, significantly outperforming four U-Net-based benchmarks (mean Dice scores: whole brainstem 0.96 vs. 0.93-0.95, pons 0.96 vs. 0.91-0.94, mesencephalon 0.96 vs. 0.89-0.93, and medulla 0.95 vs. 0.91-0.93). Results revealed severe atrophy in preclinical and symptomatic cohorts, with pons volumes reduced by nearly 50% compared to controls (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.